Sandoz Targets Chiesi Cardene Patents For PTAB Review
Generic-drug maker Sandoz Inc. has asked the Patent Trial and Appeal Board to invalidate a series of Chiesi USA Inc. patents for a ready-to-use version of its intravenous high blood pressure...To view the full article, register now.
Already a subscriber? Click here to view full article